BACKGROUND: In obese children, plasma leptin is elevated and correlates with the body mass index (BMI). In obese adults, plasma leptin decreases during weight reduction. Since the leptin system changes dynamically in puberty, we asked whether weight reduction in obese adolescents has similar consequences for plasma leptin as in overweight adults. In plasma, a portion of leptin is bound to several as yet uncharacterised proteins. We therefore studied the possible association of leptin with plasma lipoproteins. SUBJECTS AND METHODS: We measured plasma leptin, lipoprotein cholesterol and apolipoproteins (apo) A-I and B in 34 obese children (age 12.5 AE 1.9 y, relative BMI 165.0 AE 28.1%) before and after three weeks of weight reduction in a dietary camp. Lipoprotein binding of endogenous and exogenously radiolabelled leptin was studied by preparative ultracentrifugation. RESULTS: Plasma leptin was higher in obese children than in normal weight controls and fell from 16.5 AE 9.8 ngaml to 10.0 AE 8.6 ngaml after weight reduction (P`0.001). In multivariate regression, relative BMI and apoA-I were signi®cant predictors of baseline leptin and accounted for 38% (P 0.003) and 15% (P 0.006) of the variance of baseline leptin concentrations in obese children. Only the difference in plasma high-density lipoprotein (HDL)-cholesterol independently predicted the change of plasma leptin that was associated with weight reduction, explaining 29% of the variance of leptin changes (P 0.0032). A substantial portion of both endogenous and exogenously labelled leptin was recovered with HDL isolated by ultracentrifugation. CONCLUSIONS: We conclude that plasma leptin decreases in overweight children undergoing short term weight reduction. In obese children, plasma apoA-I and HDL-cholesterol are independent predictors of leptin concentrations during weight loss, respectively. In addition, HDLs transport a variable portion of leptin in the circulation.
Introduction
Leptin, the product of the ob gene, 1 is a proteohormone secreted by adipocytes and acts as a circulating satiety signal in the regulation of body weight. 2 Leptin in¯uences appetite, energy expenditure and neuroendocrine axes via a high af®nity receptor expressed mainly in the hypothalamus, but also in other tissues. 3 Leptin de®ciency or defective leptin signalling, due to mutations in the genes encoding leptin (ob) and the leptin receptor (obR), cause severe obesity in rodents. 2 In human obesity, however, ob mRNA abundance, leptin secretion from adipose tissue and circulating leptin concentrations are increased, and are positively correlated with the degree of obesity. 4 This suggests that resistance to leptin, rather than leptin de®ciency, is common in obese patients. Indeed, so far, only a single family with obesity has been reported that exhibited leptin de®ciency resulting from a frameshift mutation in the ob gene. 5 The regulation of body weight, appetite and energy expenditure in children differs from that in adults, because of energy requirements for growth and maturation. The role of leptin in this dynamic phase of body weight regulation is incompletely understood. Leptin concentrations rise into early puberty in both sexes. 6 This rise has been interpreted as a physiological resistance to leptin, allowing fat deposition during this stage of sexual development. 7 As the rise in leptin precedes the rise in gonadotropins, leptin may be a permissive factor for the onset of puberty. 8 During puberty, leptin concentrations decrease with Tanner stage in boys. In girls, plasma leptin levels remain constant through midpuberty and then rise to remain higher in adult women than in men.
In overweight children, as in obese adults, serum leptin concentrations are elevated and strongly correlate with the body mass index (BMI). 7, 9 Several studies in obese and non-obese adults showed that weight reduction results in decreased concentrations of plasma leptin, which cannot be solely explained by the loss of body fat. 4, 10, 11 In view of the possible importance of leptin for puberty, we asked whether weight reduction in adolescents would also result in decreases of plasma leptin, as has been demonstrated in adult patients.
Leptin occurs in human plasma in a free and a protein bound form. In obese individuals, the majority of leptin circulates as free hormone, while in lean subjects, the majority of leptin is protein bound. 12 The proteins binding leptin in plasma have not yet been characterised in detail. Several studies have examined the relation of plasma lipoproteins with leptin levels. 13 ± 16 These studies were conducted under stable weight conditions. A positive correlation of plasma high-density lipoproteins (HDL) with leptin has been reported in patients with polycystic ovary syndrome. 13 Two other studies in patients with metabolic syndrome and in adults with growth hormone de®ciency found no association of plasma lipoproteins with leptin concentrations.
14,15 A weak negative relationship of plasma leptin with plasma apolipoprotein (apo) A-I, the main protein constituent of HDL and with HDL triglyceride (TG), was reported in a population study of cardiovascular risk factors. 16 These con¯icting results and the paucity of information about leptin binding led us to examine this relationship in overweight adolescents.
We report here, that plasma leptin in overweight children undergoing weight reduction decreases as reported in obese adults. Moreover, we found that plasma leptin is positively correlated with plasma apoA-I concentrations independent of obesity indices and other lipoprotein fractions. Furthermore, we provide experimental evidence for leptin binding to HDL.
Patients and methods

Children
We studied all 34 obese children participating in a three week dietary camp on an inpatient basis (13 boys and 21 girls) with a mean age of 12.5 AE 1.9 y (meanAE s.d.) and 25 normal-weight healthy controls (12 boys and 13 girls) with a mean age of 12.7 AE 1.5 y (meanAE s.d.). The mean relative BMI (RBMI) of the obese children was 165.0AE 28.1% and for the control group was 98.3AE 13.9%. The controls were recruited from children referred to the outpatient clinic of the Department of Pediatrics at the University of Vienna for preanaesthetic evaluation, prior to minor elective surgery. All controls had a normal routine clinical chemistry pro®le and blood count. Informed consent for participation in the study was obtained from the parents in all obese children and controls.
Analysis of body composition
Body weight was measured with a beam balance (Seccol, Hamburg, Germany) (calibrated to 0.05 kg), height was determined using a stadiometer (Busse Design, Ulm, Germany). The relative body mass index was calculated using the reference values of Rolland-Cachera et al. 17 Body composition was determined by impedance analyses using a BIA 2001 Impedance Analyser (RJL Systems, Detroit, MI). An electric current of 800 mA and 50 kHz was applied via electrodes placed on the anterior surface of the right ankle and on the posterior surface of the right wrist of the supine patient and the resistance was measured. Duplicate measurements were taken in the morning after each participant had fasted for at least eight hours. The calibration of the analyser was checked, before each measurement, against a precision resistor. The calibration error was`0.5%. Fat free mass (FFM) was calculated using the equation of Kukaski et al:
Diet
After measurement of baseline values, the obese group received a three-week conventional hypocaloric mixed diet. Mean daily energy intake during the three week period, calculated by a dietitian, was 957AE 237 kcal, with a minimum intake of 50 g protein and 116 g carbohydratead. No electrolyte or vitamin supplementation was provided. After three weeks of diet, the mean weight loss in the obese group was 6.2 kg (range: 4.3 ± 11.4), resulting in a decrease of RMBI from 165 AE 28% to 152 AE 26%.
Laboratory methods
Blood samples were collected by venepuncture after an overnight fast. Plasma cholesterol (C) and triglycerides (TG) were determined by enzymatic methods 19,21 on a Kodak Ektachrome autoanalyser (Johnson & Johnson, Rochester, NY). Lipoproteins were fractionated by a combination of ultracentrifugation and polyanion precipitation according to LRC protocols. 21 Apo A-I, apoB and lipoprotein (a) (Lp(a)) were quantitated by immunoturbidimetric methods (Immuno, Vienna, Austria).
Leptin was measured in plasma and lipoprotein fractions by radioimmunoassay (Linco Research, Inc., St Louis, MO). 22 To study leptin binding to plasma lipoprotein fractions, 2.5 ml plasma was incubated with 0.5 ml of 125 I-labelled recombinant leptin (100 ± 150 cpmaml) at 24 C for 30 min. Lipoproteins were then fractionated by continuous density gradient ultracentifugation in a SW-41 swinging bucket rotor (Beckman Instruments, Palo ALto, CA). 23 Eight
Leptin and plasma lipoproteins in obese children M Holub et al 1.5 ml fractions were collected, dialysed exhaustively against EDTA-saline and analysed for apoA-I, HDL-C, and radioactivity. Leptin immunoreactivity was measured in density fractions of incubation mixtures consisting of plasma and saline instead of 125 I-labelled leptin. For discontinuous density gradient ultracentrifugation, 24 3 ml of incubation mixtures of plasma with or without 125 I-leptin were adjusted to a density 1.225 gaml using solid KBr, brought to a volume of 9 ml with a KBr solution of density 1.225 gaml and overlaid with 3 ml of a KBr solution of density 1.21 gaml. Tubes were centrifuged for 36 h at 38 000 rpm in a SW 41 rotor (Beckman Instruments, Palo Alto, CA). Three fractions of 4 ml each were collected, dialysed against EDTA saline and analysed for apoA-I, HDL-C, immunoreactive leptin and radioactivity.
Statistics
Data were analysed by multivariate stepwise regression analyses using the PROC REG procedure in the SAS program package (SAS for Windows, Version 6.11). Independent variables with an observed Pvalue`0.05 were retained in the models.
Results
This study included 13 female and 21 male overweight children. Anthropometric and biochemical variables before and after the three-week dietary intervention are shown in Table 1 . Baseline levels of plasma leptin were signi®cantly higher in the obese children than in a control group consisting of 12 male and 13 female non-obese children of comparable age (16.5 AE 9.8 ngaml in obese vs 5.8 AE 3.7 ngaml in controls, meanAE s.d., P`0.001, t-test for independent samples). No gender difference in plasma leptin was noted among the obese or lean children. In the obese group, the mean concentration of plasma leptin decreased to 10.0 AE 8.6 ngaml after weight reduction (meanAE s.d., P`0.001, t-test for paired samples), but remained signi®cantly higher than in the control group (P`0.05, t-test for independent samples). The weight loss was associated with a decrease in plasma C, which could be accounted for mainly by a decrease of low-density lipoprotein (LDL) and to a lesser extent of HDL-C levels.
Plasma leptin levels before and after weight reduction were correlated with baseline plasma apoA-I levels and with the differences in apoA-I and Lp(a) levels before and after weight reduction as determined by univariate analysis ( Table 2 ). The difference in plasma leptin concentrations measured before and after the dietary camp was related to the difference in HDL-C levels. None of the other plasma lipid and lipoprotein variables (total C, TG, very low-density lipoprotein-cholesterol (VLDL-C), VLDL-TG, LDL-C and apoB) showed a signi®cant correlation with plasma leptin or with the difference in leptin concentrations (data not shown). Obesity indices such as the RBMI or body fat, determined by impedance analysis, were signi®cantly correlated with plasma leptin before and after weight reduction ( Table 2 ). The change in percent body fat that resulted from the weight reduction program was associated with the change of ApoA-l apolipoprotein A-l; Lp(a) lipoprotein (a); HDL-C high density lipoprotein-cholesterol; RBMI relative body mass index; BF body fat (%); difference beforeaafter weight reduction *P`0.05, **P`0.01, ***P`0.001.
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To identify the variables that were independent predictors of plasma leptin, a multivariate stepwise regression analysis was performed (Table 3 ). In the ®rst model, baseline leptin was chosen as the dependent variable and baseline values of RBMI, percent body fat, gender, Tanner stage, apoA-I, apoB, total C, total TG, VLDL-C, LDL-C, HDL-C, and Lp(a) were used as independent variables. In this analysis, only RBMI and apoA-I remained in the model at the P`0.05 level. The model explained 53% of the total variance in baseline leptin, 38% of the variance were accounted for by RBMI and 15% by plasma apoA-I. To determine predictors of plasma leptin changes that were associated with the dietary intervention, a second multivariate regression model was calculated (Table 4) . Tanner stage, baseline leptin and the baseline concentrations and differences of RMBI, percent body fat, apoA-I, apoB, total C, total TG, VLDL-C, LDL-C, HDL-C and Lp(a) were selected as regressor variables. This analysis con®rmed the inference from univariate analyses in that the difference in plasma HDL-C was maintained as the only independent variable in this multivariate model. the HDL-C change explained 29% of the variance of the leptin difference before and after weight reduction To gain insight into the statistical relationship of leptin with two measures of HDL, we studied possible interactions of leptin with HDL. We measured the proportion of immunoreactive leptin that was associated with HDL isolated by ultracentrifugation. In addition, we incubated human plasma with 125 Ileptin and determined its association with HDL in otation experiments. A substantial portion of both exogenously added radioactive and endogenous immunoreactive leptin was recovered with the HDL fraction isolated by ultracentrifugation. In the ®rst experiment, plasma from an obese adult (with a BMI of 30 kgam 2 ) was used and 19% of the added radioactivity and 4% of the endogenous immunoreactive leptin was recovered in the HDL fraction, as judged by the¯otation pro®le of apoA-I, while the remaining leptin was recovered in the bottom fraction (Figure 1 ). No radioactively labelled or immunoassayable leptin was recovered in VLDL or LDL (fractions 1 to 4). In the second experiment, plasma from a lean (BMI 22.5) and an obese (BMI 30) patient were centrifuged at a density of 1.21 to separate plasma lipoproteins from the lipoprotein-free fraction ( Figure  2 ). In the plasma from the lean subject, a large portion of 125 I-leptin and leptin immunoreactivity was recovered in the lipoprotein containing fractions 1 and 2 (panel A). In contrast, the in plasma from the obese subject, a much smaller portion of immunoreactive leptin and 125 I-leptin was associated with the lipoprotein fractions, while the majority of radioactivity and immunoreactivity was found in the lipoprotein-free fraction (panel B).
Discussion
Studies of adult obese patients have shown a correlation of basal plasm leptin concentrations with the degree of obesity. 4, 10, 11 A decrease in plasma leptin concentrations after weight loss has been reported. 4, 10, 11 Similarly, in obese children and Table 3 Stepwise multiple linear regression using baseline leptin as the dependent variable and baseline values of relative body mass index (RBMI), percent body fat, gender, Tanner stage, apoliproteins (apo), total cholesterol, total triglyceride, very low density lipoprotein-C, low-density lipoprotein-C; high density lipoprotein-C, and Lp(a) as regressor variables Table 4 Stepwise multiple linear regression using the difference of leptin before and after weight reduction as dependent variable. Baseline leptin, gender, Tanner stage and baseline values and differences of relative body mass index, percent body fat, apolipoproteins (apo) A-I and B, total cholesterol (C), total triglyceride, very low density lipoprotein-C, low density lipoprotein-C, high density lipoprotein-C, and Lp(a) were entered as regressor variables Leptin and plasma lipoproteins in obese children M Holub et al adolescents studied under stable weight conditions, a substantial part of the variation of basal plasma leptin concentrations can be explained by the degree of obesity. 7, 9 Here we report that the response of plasma leptin to acute weight reduction is also observed in obese adolescents despite the dynamic changes in basal plasma leptin concentrations occurring during puberty. Similar results were recently reported by Falorni et al. 25 In univariate analysis, the decrease in leptin was signi®cantly correlated with the difference in body fat and with measures of obesity determined prior to, and at the end of weight reduction, as in studies of obese adults. 10, 11 Interestingly, the decrease in plasma leptin after weight reduction was also correlated with the difference in plasma HDL-C, a variable not measured in the previous studies on the effect of weight reduction on plasma leptin. The strength of this correlation became apparent in a multivariate regression analysis, when the difference of HDL-C emerged as the only signi®cant predictor of the change in plasma leptin during weight reduction and accounted for almost a third of the variation in the changes of leptin levels (Table 4) . Moreover, apoA-I, the main protein constituent of HDL, emerged as an independent predictor of plasma leptin measured before weight reduction (Table 3) . This con®rmed our unexpected ®nding of an association between plasma lipoproteins and leptin concentrations. A similar relation of plasma HDL to leptin was reported by Chapman et al, 13 who studied women with the polycystic ovary syndrome. In their study, only HDL added signi®cantly to the ability of the BMI to predict leptin concentrations, whereas other variables like plasma testosterone, sex hormone binding globulin, waist-to-hip ratio or glucose tolerance had no independent effects.
The independent association of HDL and apoA-I with plasma leptin prompted us to examine the possibility of leptin binding to lipoprotein particles. Indeed, we found that a substantial portion of both endogenous and exogenously added leptin binds to HDL, as determined by preparative ultracentrifugation. Several protein bands in human plasma, which are assumed to bind leptin, were identi®ed by Sinha et al., 12 using leptin agarose af®nity chromatography followed by SDS gel electrophoresis. Based on immunoprecipitation, they suggested that one of these proteins represents the soluble form of the leptin receptor Ob-Re. Their data, however, do not allow the assessment of the possible role of lipoproteins or apolipoproteins in leptin binding, because delipidation occurs in this system and because only data on proteins with a molecular weight of more than 60 kd were presented.
The physiological signi®cance of the association of leptin with HDL remains to be clari®ed. HDL particles have been shown to bind several proteins, such as the enzyme paraoxonase 26 and endotoxins. 27 The association of HDL with paraoxonase is thought to inhibit LDL oxidation, thereby protecting from atherosclerosis. Structurally, leptin resembles class 1 cytokines. Several binding proteins for cytokines have been described including a-2 macroglobulin, soluble cytokine receptors and extracellular matrix proteins. These proteins may serve as extracellular cytokine reservoirs, as modi®ers of cytokine activity or may mediate cytokine clearance (See Reference 28 for review). HDL may play a similar role in the leptin system. Plasma leptin levels have been shown to in¯uence the onset of sexual maturation in female mice 29 and precede the rise of gonadotropins in human puberty. 8 HDL deliver cholesterol to nonplacental steroidogenic tissues such as the adrenal gland, the testis and the ovary via a speci®c cell surface receptor for HDL, the scavenger receptor class 1B protein (SR-BI). 30 Like SR-BI, functional leptin receptors are expressed in the ovary. 31 It is conceivable that possible effects of leptin mediated by internalisation via the HDL receptor differ from effects of leptin resulting from the interaction with its cognate receptor. Patients with an almost complete Leptin and plasma lipoproteins in obese children M Holub et al de®ciency of HDL, due to mutations in the apoA-I gene, rearrangments in the apoA-IaC-IIaA-IV gene complex or Tangier disease, develop xanthomas, corneal clouding and coronary artery disease. 32, 33 Major disorders of body weight regulation or sexual maturation have not been reported to be associated with these HDL de®ciencies, nor have such disturbances been noted in apoA-I knockout mice. 34 The number of HDL de®cient patients is small, however, and systematic studies of leptin functions in apoA-I knockout mice have not been reported. Therefore, a more subtle in¯uence of HDL on leptin signalling cannot be ruled out.
Conclusion
In summary, out data show that leptin is closely correlated to plasma HDL and apoA-I in overweight children undergoing weight reduction, and that the HDL fraction contains one or several of the protein components that bind leptin in the circulation. Our observation of leptin binding to the HDL class may stimulate further research into possible consequences of this interaction for leptin physiology.
